Full Text
PSY1 SECUKINUMAB VS ADALIMUMAB E INFLIXIMAB PARA EL TRATAMIENTO DE ESPONDILITIS ANQUILOSANTE: UN ANÁLISIS DE COSTO POR RESPONDEDOR A LA SEMANA 24 DESDE UNA PERSPECTIVA ECUATORIANA

Abstract

Authors

G.F. Afanador Echeverri

Back to Volume 19, Supplemental S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×